Mohammad Adib Khumaidi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Mohammad Adib Khumaidi has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
Andi Asadul Islam
Orthopedic and Traumatology, Hasanuddin University School of Medicine, Makassar, Indonesia
1 shared publication- Andi Dwi Bahagia Febriani
Faculty of Medicine, Universitas Hasanuddin, Makassar, Indonesia
1 shared publication - Dante Saksono Harbuwono
Division of Endocrinology, Metabolism, and Diabetes, Department of Internal Medicine, Dr. Cipto Mangunkusumo National Referral Hospital, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Metabolic, Cardiovascular, and Aging Cluster, The Indonesian Medical Education and Research Institute, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia
1 shared publication - Edward Kurnia Setiawan Limijadi
Department of Clinical Pathology, Faculty of Medicine, Universitas Diponegoro, Semarang 50275, Indonesia
1 shared publication - Edwin Hadinata
School of Medicine, Faculty of Medicine, Universitas Ciputra Surabaya, Surabaya 60219, Indonesia
1 shared publication - Elli Hidayati
Universitas Muhammadiyah Jakarta
1 shared publication
Latest Publications
- Open Access
- 18 November 2026
- Published by MDPI AG in Healthcare
- Vol. 14 (22) , 3960
Integrating Artificial Intelligence into Medication Prescribing in Hospital Pharmacy Practice: A Critical Review and Proposed Stewardship Framework
Background: Hospital medication interventions are often judged by the prescriptions reviewed, discrepancies corrected, or recommendations accepted. These measures describe necessary work, but they do not establish whether patients receive safer, more effective, or less burdensome treatment. Aim: This critical narrative review aims to explore the broader role and potential applications of artificial intelligence (AI) in hospital medication prescribing and stewardship, rather than to evaluate one specific software application. This critical review examines the organizational and technological conditions that connect prescribing decisions to patient benefit in adults with multimorbidity or polypharmacy, from admission through early follow-up after discharge. Methods: Targeted searches of journal literature, citation tracing, and bibliographic verification informed a narrative appraisal of medication reconciliation, pharmacist-led optimization, deprescribing, clinical decision support, and transitional care. Results: The evidence distinguishes improvements in prescribing processes from effects on medication-related harm and health care utilization. Differences between studies may reflect patient selection, intervention delivery, baseline services, follow-up, and outcome measurement, as well as limited intervention effectiveness. We propose a hospital medication stewardship program in which verified medication information supports prioritized review, documented decisions, assigned responsibility, confirmed handover, and reassessment. Standard software, rule-based support, predictive models, and language models serve different tasks; each requires evidence proportionate to its intended clinical role. A three-condition evaluation compares usual care with a structured digital program and the same program with added artificial intelligence (AI), allowing the effect of the structured stewardship package and the incremental value of AI to be assessed separately. Clinical outcomes should be considered alongside patient experience, workload, costs, equity, and unintended effects. Conclusions: The framework is a proposal for prospective evaluation. Its central proposition is that medication stewardship should make the path from a recommendation to an implemented and reviewed decision observable, while testing whether that additional structure improves outcomes that matter to patients. AI-supported stewardship should be adopted only after prospective evidence of patient benefit, feasible delivery, acceptable burden, and equitable access.
- 18 November 2026
- Published by MDPI AG in Healthcare
- Vol. 14 (22) , 3960
Open AccessIntegrating Artificial Intelligence into Medication Prescribing in Hospital Pharmacy Practice: A Critical Review and Proposed Stewardship Framework
Background: Hospital medication interventions are often judged by the prescriptions reviewed, discrepancies corrected, or recommendations accepted. These measures describe necessary work, but they do not establish whether patients receive safer, more effective, or less burdensome treatment. Aim: This critical narrative review aims to explore the broader role and potential applications of artificial intelligence (AI) in hospital medication prescribing and stewardship, rather than to evaluate one specific software application. This critical review examines the organizational and technological conditions that connect prescribing decisions to patient benefit in adults with multimorbidity or polypharmacy, from admission through early follow-up after discharge. Methods: Targeted searches of journal literature, citation tracing, and bibliographic verification informed a narrative appraisal of medication reconciliation, pharmacist-led optimization, deprescribing, clinical decision support, and transitional care. Results: The evidence distinguishes improvements in prescribing processes from effects on medication-related harm and health care utilization. Differences between studies may reflect patient selection, intervention delivery, baseline services, follow-up, and outcome measurement, as well as limited intervention effectiveness. We propose a hospital medication stewardship program in which verified medication information supports prioritized review, documented decisions, assigned responsibility, confirmed handover, and reassessment. Standard software, rule-based support, predictive models, and language models serve different tasks; each requires evidence proportionate to its intended clinical role. A three-condition evaluation compares usual care with a structured digital program and the same program with added artificial intelligence (AI), allowing the effect of the structured stewardship package and the incremental value of AI to be assessed separately. Clinical outcomes should be considered alongside patient experience, workload, costs, equity, and unintended effects. Conclusions: The framework is a proposal for prospective evaluation. Its central proposition is that medication stewardship should make the path from a recommendation to an implemented and reviewed decision observable, while testing whether that additional structure improves outcomes that matter to patients. AI-supported stewardship should be adopted only after prospective evidence of patient benefit, feasible delivery, acceptable burden, and equitable access.
- Open Access
- 8 December 2022
- Published by Frontiers Media SA in Frontiers in Bioengineering and Biotechnology
- Vol. 10, 1089035
Is low-level laser therapy effective for patients with knee joint osteoarthritis? implications and strategies to promote laser therapy usage
Is low-level laser therapy effective for patients with knee joint osteoarthritis? implications and strategies to promote laser therapy usage
- 8 December 2022
- Published by Frontiers Media SA in Frontiers in Bioengineering and Biotechnology
- Vol. 10, 1089035
Open AccessIs low-level laser therapy effective for patients with knee joint osteoarthritis? implications and strategies to promote laser therapy usage
Is low-level laser therapy effective for patients with knee joint osteoarthritis? implications and strategies to promote laser therapy usage
- Open Access
- 6 November 2021
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 71, 103017
Effect of breastfeeding on children's health and its relationship to NRAMP1 expression: A cross-sectional study
Toddlers with exclusive breastfeeding can increase immunity in preventing infectious diseases such as Upper Respiratory Tract Infections (ARI). The body's resistance to disease is controlled by Natural Resistance-Associated Macrophage Protein 1 (NRAMP1). NRAMP1 contributes to the pathophysiology of several intercellular infections, including ARI. The purpose of this study was to determine the effect of breastfeeding on children's health and its relationship to NRAMP1 expression. A cross-sectional study was conducted on 124 toddlers in October 2020–June 2021. Toddlers were selected purposively from three Community Health Centers in Central Jakarta. The first group (n = 62) was exclusive breastfeeding and the second group (n = 62) was not exclusive breastfeeding. The characteristics of mothers and toddlers were collected using a structured questionnaire supported by medical record data. Meanwhile, NRAMP1 expression and NRAMP1 protein levels were obtained from the examination of blood samples. Examination of NRAMP1 gene mRNA expression by real-time PCR method and serum NRAMP1 protein levels by ELISA method. Data were analyzed using t-test, ANOVA, and multiple linear regression. The results obtained that the average mRNA expression of NRAMP1 gene and protein levels of NRAMP1 in infants who were not exclusive breastfeeding were 6.88 fold change (FC) and 315.02 pg/ml compared to those who received exclusive breastfeeding of 11.36 FC and 1087.74 pg./ml. Parity, immunization history, exclusive breastfeeding, and frequency of ARI were significantly associated with NRAMP1 gene mRNA expression and NRAMP1 protein levels (P < 0.05). Maternal and under-five age, gender, and nutritional status were not significantly related (P > 0.05). Exclusive breastfeeding was the dominant factor influencing NRAMP1 gene mRNA expression (OR: 4268) and NRAMP1 protein content (OR: 737,362). Antibodies obtained from exclusive breastfeeding in synergy with the NRAMP1 gene form the body's immunity in infants suffering from ARI.
- 6 November 2021
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 71, 103017
Open AccessEffect of breastfeeding on children's health and its relationship to NRAMP1 expression: A cross-sectional study
Toddlers with exclusive breastfeeding can increase immunity in preventing infectious diseases such as Upper Respiratory Tract Infections (ARI). The body's resistance to disease is controlled by Natural Resistance-Associated Macrophage Protein 1 (NRAMP1). NRAMP1 contributes to the pathophysiology of several intercellular infections, including ARI. The purpose of this study was to determine the effect of breastfeeding on children's health and its relationship to NRAMP1 expression. A cross-sectional study was conducted on 124 toddlers in October 2020–June 2021. Toddlers were selected purposively from three Community Health Centers in Central Jakarta. The first group (n = 62) was exclusive breastfeeding and the second group (n = 62) was not exclusive breastfeeding. The characteristics of mothers and toddlers were collected using a structured questionnaire supported by medical record data. Meanwhile, NRAMP1 expression and NRAMP1 protein levels were obtained from the examination of blood samples. Examination of NRAMP1 gene mRNA expression by real-time PCR method and serum NRAMP1 protein levels by ELISA method. Data were analyzed using t-test, ANOVA, and multiple linear regression. The results obtained that the average mRNA expression of NRAMP1 gene and protein levels of NRAMP1 in infants who were not exclusive breastfeeding were 6.88 fold change (FC) and 315.02 pg/ml compared to those who received exclusive breastfeeding of 11.36 FC and 1087.74 pg./ml. Parity, immunization history, exclusive breastfeeding, and frequency of ARI were significantly associated with NRAMP1 gene mRNA expression and NRAMP1 protein levels (P < 0.05). Maternal and under-five age, gender, and nutritional status were not significantly related (P > 0.05). Exclusive breastfeeding was the dominant factor influencing NRAMP1 gene mRNA expression (OR: 4268) and NRAMP1 protein content (OR: 737,362). Antibodies obtained from exclusive breastfeeding in synergy with the NRAMP1 gene form the body's immunity in infants suffering from ARI.